Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Yield10 Bioscience Inc (YTEN)
OTHER OTC:YTEN
RESEARCH TOOLSreports
Holding YTEN?
Track your performance easily
YTEN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.80 - $54.48
Previous Close$0.8
Volume2.11K
Average Volume (3M)67.16K
Market Cap
$515.32K
Enterprise Value$1.02M
Total Cash (Recent Filing)$2.82M
Total Debt (Recent Filing)$3.33M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Aug 12, 2024EPS Estimate
-$4.89Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-36.65
Shares Outstanding642,550
10 Day Avg. Volume2,854
30 Day Avg. Volume67,155
Standard Deviation0.38
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)21.33
Price to Sales (P/S)1.83
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.96
Enterprise Value/Gross Profit-0.14
Enterprise Value/Ebitda-0.07
Forecast
1Y Price Target
$2.50Price Target Upside202.88% Upside
Rating ConsensusHold
Number of Analyst Covering2
Yield10 Bioscience News
PremiumPre-Earnings
Is YTEN a Buy, Before Earnings?
PremiumCompany Announcements
Yield10 Bioscience Announces Departure of Key Executive
PremiumCompany Announcements
Yield10 Bioscience Announces Asset Sale and Planned Dissolution
PremiumCompany Announcements
Yield10 Bioscience Settles Convertible Note Early for $500K
PremiumCompany Announcements
Yield10 Bioscience Shareholders Decide on Stock and Leadership Matters
Bulls Say, Bears Say
Bulls Say
Financial PerformanceYTEN reported lower-than-expected operating expenses and a narrower GAAP loss per share, reflecting efficient cash management.
Regulatory ApprovalsThe USDA-APHIS’s Biotechnology Regulatory Services determined YTEN's genetically engineered Camelina sativa varieties can be cultivated in the US, enlarging the potential grower network and possibly reducing growing costs.
Strategic PartnershipsYTEN's licensing agreement with VISION Bioenergy Oilseeds represents the largest potential revenue stream in the company's history, signaling a pivotal advance in the commercialization of Camelina.
Bears Say
Capital RequirementsYTEN needs to raise additional capital before the end of 2Q24 to support its operations given the expected average cash burn of $2.5M per quarter.
Revenue PerformanceYTEN’s revenue fell below expectations, primarily due to a change in the company's revenue recognition policy.
Stock DelistingYTEN was delisted from the Nasdaq due to non-compliance with the minimum stockholder’s equity requirement, and began trading on the OTC.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
YTEN FAQ
What was Yield10 Bioscience Inc’s price range in the past 12 months?
Yield10 Bioscience Inc lowest stock price was $0.80 and its highest was $54.48 in the past 12 months.
What is Yield10 Bioscience Inc’s market cap?
Currently, no data Available
When is Yield10 Bioscience Inc’s upcoming earnings report date?
Yield10 Bioscience Inc’s upcoming earnings report date is Aug 12, 2024 which is 131 days ago.
How were Yield10 Bioscience Inc’s earnings last quarter?
Currently, no data Available
Is Yield10 Bioscience Inc overvalued?
According to Wall Street analysts Yield10 Bioscience Inc’s price is currently Undervalued.
Does Yield10 Bioscience Inc pay dividends?
Yield10 Bioscience Inc does not currently pay dividends.
What is Yield10 Bioscience Inc’s EPS estimate?
Yield10 Bioscience Inc’s EPS estimate is -$4.89.
How many shares outstanding does Yield10 Bioscience Inc have?
Yield10 Bioscience Inc has 642,546 shares outstanding.
What happened to Yield10 Bioscience Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yield10 Bioscience Inc?
Currently, no hedge funds are holding shares in YTEN
---
Yield10 Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.50 (202.88% Upside)
$2.50 (202.88% Upside)
Insider Transactions
Sold Shares
Worth $7.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.9%
Last 30 Days ▼ 10.1%
Last 30 Days ▼ 10.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.45%
Trailing 12-Months
Company Description
Yield10 Bioscience Inc
Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.
---
YTEN Company Deck
---
YTEN Earnings Call
Q4 2024
0:00 / 0:00
---
YTEN Stock 12 Month Forecast
Average Price Target
$2.50
▲(202.88% Upside)
Technical Analysis
---